Skip to main content

Research Repository

Advanced Search

Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis.

Migliorini, Filippo; Maffulli, Nicola; Velaj, Erlis; Bell, Andreas; Kämmer, Daniel; Eschweiler, Jörg; Hofmann, Ulf Krister

Authors

Filippo Migliorini

Nicola Maffulli

Erlis Velaj

Andreas Bell

Daniel Kämmer

Jörg Eschweiler

Ulf Krister Hofmann



Abstract

Venous thromboembolism (VTE) is a major concern following total knee arthroplasty (TKA). The optimal pharmacological prophylaxis remains, however, controversial. The present investigation compared several non-vitamin K antagonist oral anticoagulants commonly employed as VTE prophylaxis following TKA. A Bayesian network meta-analysis was conducted to compare apixaban, aspirin, dabigatran, edoxaban, enoxaparin, fondaparinux, and rivaroxaban. The outcomes of interest were to compare the rate of deep venous thrombosis (DVT), pulmonary embolism (PE), and major and minor haemorrhages. This study was conducted according to the PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions. In March 2024, PubMed, Web of Science, and Google Scholar were accessed with no time constraints. All randomised controlled trials (RCTs) comparing two or more drugs for the prevention of VTE following TKA were considered for inclusion. Data from 29,678 patients were collected. Of them, 67% (19,884 of 29,678 patients) were women. The mean age of the patients was 66.8 ± 2.8 years, and the mean BMI was 29.2 ± 1.5 kg/m . There was comparability in age, sex, and BMI at baseline. Apixaban 5 mg, dabigatran 220 mg, and rivaroxaban 10 mg were the most effective in reducing the rate of DVT. Apixaban 5 mg, enoxaparin 60 mg, and rivaroxaban 40 mg were the most effective in reducing the rate of PE. Apixaban 5 mg, rivaroxaban 10 mg, and apixaban 10 mg were associated with the lowest rate of major haemorrhages. Apixaban 5 mg and 20 mg, and dabigatran 220 mg were associated with the lowest rate of minor haemorrhages. Administration of apixaban 5 mg demonstrated the best balance between VTE prevention and haemorrhage control following TKA. Level I, network meta-analysis of RCTs. [Abstract copyright: © 2024. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.]

Citation

Migliorini, F., Maffulli, N., Velaj, E., Bell, A., Kämmer, D., Eschweiler, J., & Hofmann, U. K. (in press). Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis. European Journal of Orthopaedic Surgery and Traumatology, https://doi.org/10.1007/s00590-024-04071-w

Journal Article Type Article
Acceptance Date Aug 5, 2024
Online Publication Date Aug 10, 2024
Deposit Date Aug 27, 2024
Journal European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
Print ISSN 1633-8065
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1007/s00590-024-04071-w
Keywords Total knee arthroplasty, Haemorrhages, Pulmonary embolism, Deep vein thrombosis, Antithrombotic prophylaxis
Public URL https://keele-repository.worktribe.com/output/888104
Publisher URL https://link.springer.com/article/10.1007/s00590-024-04071-w